Is GENELUX Corp (GNLX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.5% / 30% | 25.5% / 30% | 0.0% / 30% | 18212.5% / 5% | ✗ NOT HALAL |
| DJIM | 1.5% / 33% | 25.5% / 33% | 0.0% / 33% | 18212.5% / 5% | ✗ NOT HALAL |
| MSCI | 5.4% / 33% | 89.0% / 33% | 0.0% / 33% | 18212.5% / 5% | ✗ NOT HALAL |
| S&P | 1.5% / 33% | 25.5% / 33% | 0.0% / 33% | 18212.5% / 5% | ✗ NOT HALAL |
| FTSE | 5.4% / 33% | 89.0% / 33% | 0.0% / 50% | 18212.5% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -117650.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -170.0% | |
| Return on Assets (ROA) | -77.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$21M |
| Free Cash Flow | -$22M |
| Total Debt | $2M |
| Debt-to-Equity | 14.6 |
| Current Ratio | 2.4 |
| Total Assets | $35M |
Price & Trading
| Last Close | $2.63 |
| 50-Day MA | $2.66 |
| 200-Day MA | $3.86 |
| Avg Volume | 240K |
| Beta | 0.1 |
|
52-Week Range
$1.99
| |
About GENELUX Corp (GNLX)
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer. It also offers CHOICE, a technology and discovery and development platform; and developed an extensive library of isolated and engineered oncolytic VACV immunotherapeutic product candidates. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is GENELUX Corp (GNLX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), GENELUX Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is GENELUX Corp's debt ratio?
GENELUX Corp's debt ratio is 1.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 5.4%.
What are GENELUX Corp's key financial metrics?
GENELUX Corp has a market capitalization of $111M, and revenue of $8,000. Return on equity stands at -170.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.